Galderma Group AG
GALD
Rangering i aksjer
#459
Galderma Group AG operates as a dermatology company worldwide. The company... Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Aksjekurs
$224.81
Markedsverdi
$52.42B
Endring (1 dag)
6.31%
Endring (1 år)
31.28%
Land
CH
Handel Galderma Group AG (GALD)
Kategori
Healthcare
Historikk for aksjesplitt for Galderma Group AG (GALD)
Aksjen Galderma Group AG (symbol: GALD) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 22, 2026.
Én GALD-aksje kjøpt før Oct 22, 2026 tilsvarer i dag 0 GALD-aksjer.
Den nyeste splittelsen skjedde Oct 22, 2026.
Én GALD-aksje kjøpt før Oct 22, 2026 tilsvarer i dag 0 GALD-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 0 | - |
DE
|
|
| 2 | x2 |
DE
|
|
| 0 | - |
JP
|
|
| 5 | x119 |
IN
|
|
| 19 | x47 |
CN
|
